Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.42089 | 71 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.31087 | 69 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.12121 | 68 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.40317 | 70 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.90223 | 65 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.2397 | 69 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.26463 | 69 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.0815 | 67 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.05952 | 67 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.02153 | 66 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.09742 | 67 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.06453 | 67 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.07924 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.1091 | 68 |